ONTRUZANT
ONTRUZANT
Approved
DIN Number
02524325
Drug Class
Human
Market Date
Jul 20, 2022
Company
HC
Samsung Bioepis Co., Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02524325
AIG Number0154252001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FD01 TRASTUZUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TRASTUZUMABActive
Strength: 440 MG / VIAL
Monograph: TRASTUZUMAB